← Browse by Condition
Medical Condition

thrombosis

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for thrombosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — thrombosis Clinical Trials

How many clinical trials are currently recruiting for thrombosis?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for thrombosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for thrombosis?
thrombosis research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a thrombosis clinical trial?
Eligibility criteria for thrombosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
American Thrombosis and Hemostasis Network 2 trials
Stéphane Zuily 1 trial
Changhai Hospital 1 trial
University Medical Center Groningen 1 trial
University of Arizona 1 trial

Recruiting Clinical Trials

NCT04262492
Recruiting
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Enrollment
500 pts
Location
France
Sponsor
Stéphane Zuily
View Trial →
NCT05864638
Recruiting
Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study
Enrollment
10,000 pts
Location
China
Sponsor
Changhai Hospital
View Trial →
NCT06820515
Recruiting
ATHNdataset Registry
Enrollment
200,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost...
View Trial →
NCT04615065
Recruiting
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Enrollment
35,000 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT04398628
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost...
View Trial →
NCT02972385
Recruiting
Pharmacogenomics of Warfarin in Hispanics and Latinos
Enrollment
400 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT07301892
Recruiting
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Enrollment
100 pts
Location
China
Sponsor
Guang'anmen Hospital of China ...
View Trial →
NCT07813377
Recruiting
Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM)
Enrollment
100 pts
Location
Spain
Sponsor
Fundacion Clinic per a la Rece...
View Trial →
NCT05245877 Phase 4
Recruiting
Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
Enrollment
800 pts
Location
Canada, Finland, Nor...
Sponsor
Helsinki University Central Ho...
View Trial →

Related Conditions

hemophilia (2) sickle cell disease (2) bleeding disorder (2) von willebrand diseases (2) hemorrhage (2) antiphospholipid syndrome (1) anticoagulants causing adverse effects in therapeutic use (1) acute ischemic stroke (1) large vessel occlusion (1) thrombectomy (1) hemophilia a (1) hemophilia b (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology